Guest: Janet, Woodcock, MD, Director, CDER, FDA
Bio and Contact Info Listen (4:41) No agency charged with better translational outcomes
Share this post

Janet Woodcock, FDA, on Biomarker Development and the Future of Clinical Trials
www.mendelspod.com
Mendelspod Podcast
Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.
Listen on
Substack App
Apple Podcasts
RSS Feed
Janet Woodcock, FDA, on Biomarker Development and the Future of Clinical Trials